FOXO4-DRI vs Pinealon
Side-by-side price comparison across every tracked vendor. Updated every 4–6 hours.
Pepticker may earn affiliate commissions (typically 5-20%) from linked vendors. See our Affiliate Disclosure.
FOXO4-DRI
Senolytic peptide
Pinealon
Pineal bioregulator tripeptide
About FOXO4-DRI
A D-retro-inverso peptide designed to disrupt the FOXO4-p53 interaction, studied for selective clearance of senescent cells.
About Pinealon
Pinealon is a Khavinson short-peptide bioregulator with the sequence Ala-Glu-Asp (AED) — sometimes listed as the AEDG tetrapeptide in vendor catalogs — derived from pineal-gland extracts in Russian gerontology research. It has been studied in animal and cell-culture models for neuroprotection, oxidative-stress resistance, and circadian-rhythm regulation, typically alongside the related pineal tetrapeptide Epitalon (AEDG). Sold by research-peptide vendors at 5–20 mg vial sizes for laboratory work; not approved by FDA, MHRA, Health Canada, or TGA for human use. Research-use only — Pepticker does not provide medical advice and this entry summarises published preclinical research, not a dosing protocol.